Featuring Emma Ashford, Visiting Fellow, Defense and Foreign Policy, Cato Institute, (@emmamashford); Erica Borghard, Assistant Professor, U.S. Military Academy (West Point), (@eborghard); and Nicholas Heras, Research Associate, Middle East Security Program, Center for a New American Security; moderated by Justin Logan, Director of Foreign Policy Studies, Cato Institute, (@JustinTLogan).
For libertarians, the basic unit of social analysis is the individual. Individuals are, in all cases, the source and foundation of creativity, activity, and society. In the new issue of Cato Policy Report, Cato scholar David Boaz, author of The Libertarian Mind: A Manifesto for Freedom, explains the roles and rights of individuals in a free society, and cautions against a vision of a world in which individuals have no way to cooperate with others except through the state.
Two long wars, chronic deficits, the financial crisis, the costly drug war, the growth of executive power under Presidents Bush and Obama, and the revelations about NSA abuses, have given rise to a growing libertarian movement in our country – with a greater focus on individual liberty and less government power. David Boaz’s newly released The Libertarian Mind is a comprehensive guide to the history, philosophy, and growth of the libertarian movement, with incisive analyses of today’s most pressing issues and policies.
Featuring J. Scott Ballenger, Partner, Latham & Watkins; Ezekiel J. Emanuel, Chair, Department of Clinical Bioethics, National Institutes of Health; and Michael F. Cannon, Director of Health Policy Studies, Cato Institute.
In Abigail Alliance for Better Access to Developmental Drugs v. Eschenbach, terminally ill patients won an impressive victory before a panel of the U.S. Court of Appeals for the D.C. Circuit. That panel ruled that when the government prevents terminally ill patients from accessing experimental drug treatments, it violates those patients’ constitutionally protected right to save their own lives. On appeal, however, an en banc opinion from the D.C. Circuit overturned the panel opinion, setting the stage for an appeal to the Supreme Court. Please join Michael F. Cannon, the Cato Institute’s director of health policy studies; Scott Ballenger, lead counsel for the Abigail Alliance; and Ezekiel Emanuel, a leading critic of the Abigail Alliance’s case as they discuss the economics, ethics, and constitutionality of allowing the state to stand between dying patients and unproven therapies.